Blog

Tag: pharma commercialization

The Hidden Driver of Gross to Net Erosion Is Patient Abandonment

Post author By Hoot
Post date March 26, 2026

For more than a decade, pharmaceutical leaders have treated gross to net as a pricing problem. The focus has been on rebates, PBMs, formulary positioning, and increasingly complex contracting strategies. Entire teams are dedicated to modeling discount structures and negotiating access. Yet despite all of this effort, the gap between list price and net revenue […]

Tags gross to net, patient abandonment, patient adherence, Patient Education, pharma commercialization

Why Patient Services Is Breaking as Pharma Goes Direct to Patient

Post author By Hoot
Post date February 2, 2026

Listen to Episode 1: Pharma’s Direct to Patient Pivot: What to Expect in 2026 here. The pharmaceutical industry is moving faster than patients can keep up. Therapies are becoming more specialized. Disease education is more complex. Access models are shifting Direct to Patient. At the same time, physician time is shrinking and patients are being […]

Tags healthcare innovation, patient access, Patient Education, patient engagement, Patient Services, pharma commercialization, Pharma Direct to Patient, pharma leadership, pharma marketing, Specialty Pharma